Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-2-27
pubmed:abstractText
The authors compared the pharmacokinetics and pharmacological effects of the immunomodulator fingolimod in healthy white and Asian subjects for potential ethnic differences.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0946-1965
pubmed:author
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
98-109
pubmed:dateRevised
2008-6-5
pubmed:meshHeading
pubmed-meshheading:17323789-Area Under Curve, pubmed-meshheading:17323789-Asian Continental Ancestry Group, pubmed-meshheading:17323789-Dose-Response Relationship, Drug, pubmed-meshheading:17323789-Double-Blind Method, pubmed-meshheading:17323789-Drug Administration Schedule, pubmed-meshheading:17323789-European Continental Ancestry Group, pubmed-meshheading:17323789-Female, pubmed-meshheading:17323789-Heart Rate, pubmed-meshheading:17323789-Humans, pubmed-meshheading:17323789-Immunosuppressive Agents, pubmed-meshheading:17323789-Lymphocyte Count, pubmed-meshheading:17323789-Lymphocytes, pubmed-meshheading:17323789-Male, pubmed-meshheading:17323789-Metabolic Clearance Rate, pubmed-meshheading:17323789-Metabolic Detoxication, Drug, pubmed-meshheading:17323789-Propylene Glycols, pubmed-meshheading:17323789-Sphingosine
pubmed:year
2007
pubmed:articleTitle
Ethnic sensitivity study of fingolimod in white and Asian subjects.
pubmed:affiliation
Novartis Pharmaceuticals, Basle, Switzerland. john.kovarik@Novartis.com
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II, Clinical Trial, Phase I